Related Experiment Video

Updated: Oct 3, 2026

Non-Invasive Model of Neuropathogenic Escherichia coli Infection in the Neonatal Rat
08:27

Non-Invasive Model of Neuropathogenic Escherichia coli Infection in the Neonatal Rat

Published on: October 29, 2014

Bacterial meningitis: current controversies in approaches to treatment

A J Williams1, S Nadel

  • 1Department of Paediatric Infectious Diseases, St Mary's Hospital, London, UK.

CNS Drugs
|December 12, 2001
PubMed

Insights

Acute bacterial meningitis remains a critical global health threat with high mortality and morbidity. Antibiotic resistance, particularly in Streptococcus pneumoniae, presents the biggest therapeutic challenge.

Area of Science:

  • Infectious Diseases
  • Microbiology
  • Neurology

Background:

  • Acute bacterial meningitis causes significant global mortality and morbidity in children and adults.
  • Key pathogens include Neisseria meningitidis, Streptococcus pneumoniae, and Haemophilus influenzae type b (Hib), with variations by age and immune status.
  • Antibiotic resistance, especially in Streptococcus pneumoniae, complicates treatment and impacts outcomes.

Purpose of the Study:

  • To review the current landscape of acute bacterial meningitis, including causative agents, challenges, and therapeutic advancements.
  • To discuss the impact of antibiotic resistance on meningitis treatment strategies.
  • To evaluate the role of vaccination and adjunctive therapies in managing bacterial meningitis.

Main Methods:

  • Literature review of studies on bacterial meningitis epidemiology, pathophysiology, diagnosis, and treatment.
  • Analysis of data on antibiotic resistance patterns for common meningitis pathogens.
  • Evaluation of evidence for adjunctive therapies like corticosteroids and the impact of vaccines.

Main Results:

  • Vaccination has significantly reduced Haemophilus influenzae type b (Hib) and serogroup C meningococcal meningitis incidence.
  • Antibiotic resistance, particularly penicillin and cephalosporin resistance in Streptococcus pneumoniae, is a growing concern.
  • The efficacy of adjunctive corticosteroids is clearer in children (reducing neurological sequelae) than in adults.

Conclusions:

  • Despite advances, bacterial meningitis remains a serious disease, with antibiotic resistance posing the primary therapeutic challenge.
  • Vaccination strategies have proven effective in reducing the incidence of specific types of bacterial meningitis.
  • Further research is needed to optimize treatment protocols and combat emerging antibiotic resistance in meningitis management.

More Related Videos

Inducing Meningococcal Meningitis Serogroup C in Mice via Intracisternal Delivery10:03

Inducing Meningococcal Meningitis Serogroup C in Mice via Intracisternal Delivery

Published on: November 5, 2019

The Adjuvant Efficacy of Angong Niuhuang Pill in the Treatment of Viral Encephalitis: A Meta-Analysis of Randomized Controlled Trials08:36

The Adjuvant Efficacy of Angong Niuhuang Pill in the Treatment of Viral Encephalitis: A Meta-Analysis of Randomized Controlled Trials

Published on: April 19, 2024

Related Concept Videos

Bacterial Meningitis I: Introduction01:22

Bacterial Meningitis I: Introduction

Bacterial meningitis is a severe, life-threatening inflammation of the meninges, particularly the pia mater and arachnoid mater, affecting the subarachnoid space, ventricles, and cerebrospinal fluid (CSF). If untreated, it can lead to significant neurological complications or death.Causative AgentsCommon pathogens vary with age and immune status. In adults, major organisms include Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae. Streptococcus agalactiae (group B...
Bacterial Meningitis01:24

Bacterial Meningitis

Bacterial meningitis is a severe infectious disease involving inflammation of the meninges, the protective membranes surrounding the brain and spinal cord. It occurs when pathogenic bacteria cross the blood–brain barrier and enter the cerebrospinal fluid. Common causative organisms include Neisseria meningitidis, Streptococcus pneumoniae, Haemophilus influenzae type b, Listeria monocytogenes, and Escherichia coli K1. The exact route of entry varies by pathogen and host condition.Routes of Entry...
Bacterial Meningitis II: Pathophysiology01:26

Bacterial Meningitis II: Pathophysiology

Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...
Viral Meningitis01:18

Viral Meningitis

Viral meningitis is the most common form of meningitis and is often referred to as aseptic meningitis to indicate the absence of bacterial involvement. It is generally milder than bacterial meningitis, with symptoms including fever, headache, stiff neck, drowsiness, nausea, photophobia, and vomiting. Rarely, more severe manifestations or death may occur. Common causative agents include enteroviruses, particularly coxsackie A and B viruses and echoviruses, all members of the Enterovirus genus...
Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Brain Abscess l: Introduction01:26

Brain Abscess l: Introduction

A brain abscess is a focal, intracerebral infection characterized by a localized collection of pus within the brain parenchyma, resulting from microbial invasion and the body’s inflammatory response. It progresses through stages: early and late cerebritis, followed by early and late capsule formation, reflecting tissue destruction, immune response, and eventual encapsulation.Etiology and PathogenesisCausative organisms vary with source and host factors, often involving polymicrobial infections,...